Search results for "coronavirus 2"

showing 10 items of 549 documents

Suddenly Working From Home!

2022

Abstract. The Corona crisis and the lockdown in the spring of 2020 had various effects on working life in Europe. In this three-wave study, we assessed the trajectories of job demands and resources of 302 employees 2 weeks before the lockdown, over 1 week after lockdown start, and 6 weeks following the beginning of the lockdown. We applied a pre-post follow-up design with 129 employees who switched to telecommuting and a control group of 173 employees who remained in their on-site workplace. Results from the repeated-measures MANCOVA indicate that, despite various general changes to job characteristics because of the Corona crisis, telecommuting changes contributed to significant changes on…

Organizational Behavior and Human Resource ManagementWorking life2019-20 coronavirus outbreakLabour economicsJob demands-resources modelTelecommutingCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BusinessApplied PsychologyZeitschrift für Arbeits- und Organisationspsychologie A&O
researchProduct

Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

2021

Abstract Background Little is known about characteristics of seasonal human coronaviruses (HCoVs) (NL63, 229E, OC43, and HKU1) after allogeneic stem cell transplantation (allo-HSCT). Methods This was a collaborative Spanish and European bone marrow transplantation retrospective multicenter study, which included allo-HSCT recipients (adults and children) with upper respiratory tract disease (URTD) and/or lower respiratory tract disease (LRTD) caused by seasonal HCoV diagnosed through multiplex polymerase chain reaction assays from January 2012 to January 2019. Results We included 402 allo-HSCT recipients who developed 449 HCoV URTD/LRTD episodes. Median age of recipients was 46 years (range,…

PNEUMONIAMalevirusesmedicine.medical_treatmentseasonal human coronavirusHematopoietic stem cell transplantationmedicine.disease_causeDISEASElaw.inventionCoronavirus OC43 HumanCLINICAL CHARACTERISTICSlawCoronavirus 229E HumanRisk FactorsImmunology and AllergyChildRespiratory Tract InfectionsNL63 INFECTIONSCoronavirusOUTCOMESRespiratory tract infectionsSYNCYTIAL VIRUSHazard ratioHematopoietic Stem Cell Transplantationvirus diseasesupper and lower respiratory tract diseaseHCoV-NL63HCoV-229Erespiratory systemMiddle AgedIntensive care unitHospitalizationimmunocompromisedsurgical procedures operativeInfectious Diseasesmedicine.anatomical_structureAcademicSubjects/MED00290Child PreschoolCohortFemaleSeasonsCoronavirus InfectionsRare cancers Radboud Institute for Health Sciences [Radboudumc 9]allogeneic hematopoietic stem cell transplantation; community-acquired respiratory virus; HCoV-229E; HCoV-HKU1; HCoV-NL63; HCoV-OC43; immunocompromised; immunodeficiency score index; multiplex PCR assay; seasonal human coronavirus; upper and lower respiratory tract diseaseAdultmedicine.medical_specialtyHCoV-OC43AdolescentDIAGNOSISCHINAHCoV-HKU1BetacoronavirusAll institutes and research themes of the Radboud University Medical Centerstomatognathic systemInternal medicinemedicineMajor ArticleRHINOVIRUSHumansallogeneic hematopoietic stem cell transplantationAgedRetrospective Studiescommunity-acquired respiratory virusbusiness.industryInfantmultiplex PCR assayTransplantationCoronavirus NL63 HumanPARAINFLUENZA VIRUSbusinessimmunodeficiency score indexRespiratory tract
researchProduct

Public Transport Passenger Count Forecasting in Pandemic Scenarios Using Regression Tsetlin Machine. Case Study of Agder, Norway

2021

Challenged by the effects of the COVID-19 pandemic, public transport is suffering from low ridership and staggering economic losses. One of the factors which triggered such losses was the lack of preparedness among governments and public transport providers. The losses can be minimized if the passenger count can be predicted with a higher accuracy and the public transport provision adapted to the demand in real time. The present paper explores the use of a novel machine learning algorithm, namely Regression Tsetlin Machine, in using historical passenger transport data from the current COVID-19 pandemic and pre-pandemic period, combined with a calendar of pandemic-related events (e.g. daily …

Passenger transport2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryComputer scienceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Public transportPreparednessPandemicEconometricsbusinessRegression
researchProduct

Papulo-purpuric dermatitis of childhood: a distinct PLEVA-like eruption associated to SARS-CoV-2 infection. Clinical, histopathological and immunohis…

2021

Abstract We observed ten children with a papular eruption with purpuric features during the SARS‐CoV‐2 pandemic in Northern Italy (May‐December 2020). Histological examination showed signs of SARS‐CoV‐2‐related dermatosis. Evidence of nucleocapsid viral proteins using SARS‐CoV‐2 (2019‐nCoV) nucleocapsid antibody revealed cuticular staining of the deep portion of the eccrine glands in all cases.

Pathologymedicine.medical_specialtySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesdermatopathology pediatric PLEVA SARS-CoV-2 skin histopathology Humans Pandemics SARS-CoV-2 COVID-19 Dermatitis PurpuraDermatitisDermatologySARS‐CoV‐2Eccrine glandMedicineHumansskin and connective tissue diseasesdermatopathologyPandemicsPurpuraHistological examinationbiologybusiness.industrySARS-CoV-2fungiskin histopathologyCOVID-19Original ArticlesNorthern italyStainingrespiratory tract diseasesbody regionspediatricPLEVAPediatrics Perinatology and Child Healthbiology.proteinImmunohistochemistryOriginal ArticleDermatopathologyAntibodybusiness
researchProduct

Data from 235 Cases of Bell's Palsy during COVID-19 Pandemic: Were There Clusters of Facial Palsy?

2021

Sin financiación 5.393 JCR (2021) Q1, 49/212 Clinical Neurology 1.204 SJR (2021) Q1, 79/378 Neurology (clinical) No data IDR 2020 UEM

Pediatricsmedicine.medical_specialty2019-20 coronavirus outbreakPalsyParálisis de BellCoronavirus disease 2019 (COVID-19)Epidemiologybusiness.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Facial ParalysisEnfermedad del sistema nerviosoCOVID-19medicine.diseaseVirusEfectos fisiológicosPandemicBell's palsymedicineBell PalsyHumansNeurology (clinical)businessPandemicsLetter to the Editor
researchProduct

Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study

2021

Background: Many aspects of SARS-CoV-2 infection in children and adolescents remain unclear and optimal treatment is debated. The objective of our study was to investigate epidemiological, clinical and therapeutic characteristics of pediatric SARS-CoV-2 infection, focusing on risk factors for complicated and critical disease.Methods: The present multicenter Italian study was promoted by the Italian Society of Pediatric Infectious Diseases, involving both pediatric hospitals and general pediatricians/family doctors. All subjects under 18 years of age with documented SARS-CoV-2 infection and referred to the coordinating center were enrolled from March 2020.Results: As of 15 September 2020, 75…

Pediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MIS-CDisease030204 cardiovascular system & hematologyPediatrics03 medical and health sciences0302 clinical medicinechildren030225 pediatricsEpidemiologymedicinebookOriginal Researchmultisystem inflammatory syndromeMIS-C COVID-19business.industrySARS-CoV-2 infectionDisease progressionlcsh:RJ1-570COVID-19lcsh:PediatricsSettore MED/38Icu admissionCOVID-19; MIS-C; SARS-CoV-2 infection; children; multisystem inflammatory syndromeMulticenter studyPediatrics Perinatology and Child HealthPediatric Infectious Diseasebook.journalbusiness
researchProduct

Cardiovascular and Cardioprotective Agents in 2021

2021

Pharmacology2019-20 coronavirus outbreakCardiotonic AgentsCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cardiovascular AgentsPharmacologyCardiovascular SystemCardiovascular DiseasesDrug DiscoveryCardiovascular agentHumansMedicineCardioprotective AgentbusinessCurrent Pharmaceutical Design
researchProduct

Le pharmacien et le consentement éclairé

2021

During the implementation of the Covid-19 vaccination, the issue of consent was widely commented upon. Many confusions arose between the withdrawal period, the obligation to collect written consent and many other more or less fanciful concepts. Informed consent is one of the founding stones of health democracy. It deserves to be understood in order to be intelligently applied.

Pharmacology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Informed consentmedia_common.quotation_subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)LawPharmacistPharmacology (medical)ObligationPsychologyDemocracymedia_commonActualités Pharmaceutiques
researchProduct

Vaccin contre la Covid-19, une course contre le temps

2021

Pharmacology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePharmacology (medical)businessVirologyArticleActualités Pharmaceutiques
researchProduct

Diabetes and COVID-19: A Tale of 2 Pandemics.

2021

Abstract: Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19 (coronavirus disease 2019). Dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, exerts direct cardioprotective and nephroprotective effects. DARE-19 (Dapagliflozin in Respiratory Failure in Patients With COVID-19), an ongoing clinical trial, is designed to investigate the impact of dapagliflozin on COVID-19 progression. This article discusses the potential favorable impact of dapagliflozin on COVID-19 and its complications.

Pharmacology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)diabetesbusiness.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19Review Articledapagliflozinmedicine.diseaseVirologyDARE-19Diabetes mellitusPandemicmedicineDiabetes MellitusHumansSGLT2iCardiology and Cardiovascular MedicinebusinessPandemicsHumans Pandemics SARS-CoV-2 COVID-19 Diabetes MellitusJournal of cardiovascular pharmacology
researchProduct